Peyman Danesh
Podiatrist · Las Vegas, NVNPI 1780180729
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $418 of the $498 with a category attached, or 83.9%. 7 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 25.0% of the total. Reporting peaked in 2021 at $285 and has fallen 74.2% since, to $74 in 2025. That places this record below the midpoint for podiatrist clinicians in NV, where the typical reported total is $833.
Across 16 payments — averaging $31.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$125
- Royal Biologics, Inc.$124
- Osteomed LLC$80
- Aroa Biosurgery Incorporated$74
- Stryker$45
- AbbVie$36
- plus $14 from 1 others
What the payments were for
- Food & beverage$41884%
- Education$8016%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 5 | $125 |
| Royal Biologics, Inc. | 4 | $124 |
| Osteomed LLC | 1 | $80 |
| Aroa Biosurgery Incorporated | 2 | $74 |
| Stryker | 1 | $45 |
| AbbVie | 2 | $36 |
| Averitas Pharma Inc. | 1 | $14 |
How this compares
$498 in reported general payments places this provider in the 40th percentile of 44 podiatrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 70 | $1,811 |
| Ketoconazole | 58 | $761 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $97 |
| Meloxicam | 37 | $79 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Las Vegas
- Anthony RicciardiLas Vegas$498K
- Jeremy AndersonLas Vegas$72K
- He XuLas Vegas$54K
- Peter BregmanLas Vegas$18K
- Anmy VuLas Vegas$15K
- Ai Quoc HellerLas Vegas$8K
- John CadeLas Vegas$6K
- Ada VeraLas Vegas$5K
- Michael ChildsLas Vegas$4K
- Justin ColarcoLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.